IBC Life Sciences

Name

IBC Life Sciences

Website

https://ibclifesciences.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Professional Conferences and Training

akta.pro primary industry

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Pharmaceutical conferences
• Biotechnology training
• Life sciences events
• Expert-led courses
• Biopharma professional education

Headquarters

HQ city

Westborough

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Core offering

IBC Life Sciences produces expert-led conferences, courses, and online communities serving the global pharmaceutical and biotechnology industries. Its portfolio spans topic areas including partnering and business development, bioprocessing, antibody engineering, cell and gene therapy, regulatory affairs, clinical and medical affairs, pricing and contracting, and life-sciences finance, marketed under sub-brands such as EBD Group, LSX, Xconomy, and Clinical Insider.

Product overview

Informa Connect's Biotech & Pharma division offers a platform of event categories and topic areas for the global life science industry. The portfolio includes multiple branded event series (such as EBD Group, LSX, Xconomy, and Clinical Insider) spanning partnering and business development, bioprocessing, antibody engineering, cell and gene therapy, peptides and oligonucleotides, regulatory affairs, clinical and medical affairs, investment and fintech, and various other specialized topics. This is a multi-brand event and content platform providing resources for commercial success in the life sciences sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Partnering, Business Development & Licensing Events Events, news, and information for the people who influence the business strategies of the life science industry.
• Bioprocessing & Manufacturing Conferences and content providing access to the science, technology, and contacts needed to accelerate biologics and novel products toward commercial success.
• Antibody Engineering Events covering the latest science, technology, and partners in antibody engineering, immunobiology, and next-generation binders.
• Cell & Gene Therapy Events aimed at fast-tracking cell, gene, and CAR-T commercialization from concept to robust patient-centric delivery.
• Peptides & Oligonucleotides Conferences described as the world's largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development and commercialization.
• Clinical & Medical Affairs Events addressing cutting-edge approaches to trial and study design, technology, sourcing, data disclosure, and medical communications.
• Regulatory Affairs, Biotech & Pharma Conferences and training covering regulatory and e-regulatory topics for the pharmaceutical industry.
• Pricing & Contracting Events providing strategies to position products and value propositions effectively with government and commercial payers in a complex and competitive marketplace.
• EBD Group A partnering platform facilitating the strategic connections that drive drug development.
• LSX A networking community for senior life science industry decision-makers to access innovators, capital, and partners.
• Quality & Validation Events focused on optimizing lab, production, and manufacturing processes, IT systems, and quality control with access to industry-respected content.
• Compliance & Legal, Biotech & Pharma Events in which leaders share insight and experiences that shape the future of biotech.
• Business Strategy & Leadership Events where leaders share insight and experiences that shape the future of biotech.
• Access & Channel Events covering next-generation patient services, support models, and network distribution strategies to accelerate access and uptake.
• Finance & Accounting, Life Sciences Events offering industry-specific guidance, benchmarking on standards, and practical expertise to minimize uncertainty and drive corporate growth.
• Talent, Diversity & Inclusion, Life Sciences Events presenting practical solutions and case studies to propel diversity and inclusion throughout organizations in life sciences.
• Meetings & Medical Communications Events, experts, and engagement for delivering innovative and compliant meetings and promotional programs.
• Investment in Biotech, MedTech & Digital Health Events for discovering and investing in the most innovative companies in medtech, digital health, AI, and biotechnology.
• Startups & Innovators Content and events covering the hottest companies and technologies in biotechnology, and insight to help startups succeed.
• Xconomy Timely, insightful, close-to-the-scene information on the personalities, companies, and trends that exemplify today's innovation economy.
• Clinical Insider Weekly newsletter offering news, analysis, and insider insights on the clinical trials industry delivered by email.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights4 records

Direct peers

• Drug Information Association (DIA): Global life-sciences association running major conferences, training, and content on regulatory affairs, clinical trials, and pharmacovigilance — directly overlaps IBC Life Sciences' regulatory and clinical affairs verticals.
• American Society of Clinical Oncology (ASCO): Operates the largest oncology congresses (ASCO Annual Meeting, thematic conferences), which compete with IBC Life Sciences' clinical and medical affairs events for oncology KOL attendance and pharma sponsorship dollars.
• Hanson Wade: Specialist organizer of life-sciences conferences focused on biopharma R&D, cell & gene therapy, and drug development — competes head-to-head for the same pharma KOL and sponsor wallet as IBC Life Sciences.
• Cambridge Healthtech Institute (CHI): Long-standing life-sciences conference organizer running events across biologics, clinical trials, and pharma R&D — directly comparable portfolio, similar audience of pharma executives, and same B2B conference business model as IBC Life Sciences.
• Biotechnology Innovation Organization (BIO): Runs the BIO International Convention and BIO-Europe partnering conferences, the flagship global events for biotech business development and partnering — directly comparable to IBC Life Sciences' EBD Group partnering franchise.
• American Society of Hematology (ASH): Annual meeting and specialty conferences in hematology attract overlapping pharma sponsors and clinician audiences that also attend IBC Life Sciences' cell & gene therapy and antibody engineering events.

Broad incumbents

• Elsevier (Life Sciences Events): Major academic publisher that also runs conferences and continuing education for pharma and life-sciences professionals; not a direct one-to-one competitor but adjacent in audience and content monetization.
• Questex: B2B events and media company operating life-sciences and healthcare event brands (including Fierce Biotech); broader portfolio than IBC Life Sciences but directly comparable B2B conference and content business model.
• Informa Markets: The larger B2B events and exhibitions arm of IBC Life Sciences' apparent parent Informa PLC; operates global pharma, life-sciences, and healthcare event portfolios at significantly greater scale, providing both direct and indirect competition.

Others

• Clarivate: Provides life-sciences intelligence, data, and some event programming serving the same biopharma R&D audience; not a direct events competitor but adjacent in monetizing pharma KOL engagement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/ibcusa
• Facebookfacebook.com/ibclifesciences

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IBC Life Sciences